A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia

Shaoyong Xu(Hubei University of Arts and Science), Qiuhe Ji(Xijing Hospital), Shenren Chen(Shantou University), Haiwang Ji(Shaanxi Provincial People's Hospital), Xiumei Liu(Dalian University of Foreign Languages), Xiangyang Liu(Nankai University), Ying Lü(Beijing University of Chinese Medicine), Hong Liu(Guangxi Medical University), Yonghong Zhang(Soochow University), Jinying Lin(The People's Hospital of Guangxi Zhuang Autonomous Region), Peng Liu(Zhejiang Cancer Hospital), Yangang Wang(Qingdao University), Jianqin Wang(Lanzhou University Second Hospital), Yongde Peng(Tongren Hospital), Bin Liu(Fujian Electric Power Survey & Design Institute), Jie Ming(Union Hospital)
International Journal of Rheumatic Diseases
May 27, 2015
Cited by 55


Related Papers